Sonalleve
Posts
News
https://profoundmedical.com/wp-content/uploads/2019/04/CF041119_SM_0141_edited.jpg
2833
4250
ProfoundMarketing
http://profoundmedical.com/wp-content/uploads/2018/06/profound-logo-2018-e1547242475901.png
ProfoundMarketing2019-04-15 15:47:232019-04-15 16:37:16Analyst & Investor Day: Recap
https://profoundmedical.com/wp-content/uploads/2019/04/Profound_Logo-on-Blue.jpg
675
1200
ProfoundMarketing
http://profoundmedical.com/wp-content/uploads/2018/06/profound-logo-2018-e1547242475901.png
ProfoundMarketing2019-04-05 15:42:532019-04-15 16:36:32TACT Pivotal Clinical Trial of TULSA-PRO®: All Primary Efficacy and Safety Endpoints, and Key Secondary Endpoints Achieved
https://profoundmedical.com/wp-content/uploads/2016/09/PROFOUND_THERMAL-2.jpg
4392
4376
Profound Medical
http://profoundmedical.com/wp-content/uploads/2018/06/profound-logo-2018-e1547242475901.png
Profound Medical2019-03-28 13:39:542019-04-05 12:43:08TULSA-PRO: Software version 2.8 releaseHead Office
Profound Medical Corp.,
2400 Skymark Avenue,
Unit #6, Mississauga, ON L4W 5K5, Canada
T: 647.476.1350
F: 647.847.3739
info@profoundmedical.com